133 related articles for article (PubMed ID: 37997255)
1. Multiomics blueprint of PANoptosis in deciphering immune characteristics and prognosis stratification of glioma patients.
Chen M; Huang M; Chen X; Lin X; Chen X
J Gene Med; 2024 Jan; 26(1):e3621. PubMed ID: 37997255
[TBL] [Abstract][Full Text] [Related]
2. Identification of PANoptosis-related predictors for prognosis and tumor microenvironment by multiomics analysis in glioma.
Sun F; Liao M; Tao Z; Hu R; Qin J; Tao W; Liu W; Wang Y; Pi G; Lei J; Bao W; Dong Z
J Cancer; 2024; 15(9):2486-2504. PubMed ID: 38577605
[TBL] [Abstract][Full Text] [Related]
3. Robust analysis of a novel PANoptosis-related prognostic gene signature model for hepatocellular carcinoma immune infiltration and therapeutic response.
Wei Y; Lan C; Yang C; Liao X; Zhou X; Huang X; Xie H; Zhu G; Peng T
Sci Rep; 2023 Sep; 13(1):14519. PubMed ID: 37666920
[TBL] [Abstract][Full Text] [Related]
4. The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas.
Song J; Xu Z; Fan Q; Sun Y; Lin X
Front Mol Neurosci; 2023; 16():1198713. PubMed ID: 37501725
[TBL] [Abstract][Full Text] [Related]
5. Exploring PANoptosis in breast cancer based on scRNA-seq and bulk-seq.
He P; Ma Y; Wu Y; Zhou Q; Du H
Front Endocrinol (Lausanne); 2023; 14():1164930. PubMed ID: 37455906
[TBL] [Abstract][Full Text] [Related]
6. Machine learning reveals PANoptosis as a potential reporter and prognostic revealer of tumour microenvironment in lung adenocarcinoma.
Han C; Danzeng Q; Li L; Bai S; Zheng C
J Gene Med; 2024 Jan; 26(1):e3599. PubMed ID: 37800684
[TBL] [Abstract][Full Text] [Related]
7. Systematic analysis of PANoptosis-related genes identifies XIAP as a functional oncogene in breast cancer.
Qi Q; Zhu M; Li P; Mi Q; Xie Y; Li J; Wang C
Gene; 2024 Jun; 912():148355. PubMed ID: 38467314
[TBL] [Abstract][Full Text] [Related]
8. Molecular subtypes based on PANoptosis-related genes and tumor microenvironment infiltration characteristics in lower-grade glioma.
Abulaiti A; Maimaiti A; Yiming N; Fu Q; Li S; Li Y; Wang Y; Zhou Q
Funct Integr Genomics; 2023 Mar; 23(2):84. PubMed ID: 36930242
[TBL] [Abstract][Full Text] [Related]
9. Identification of a PANoptosis-related Gene Signature for Predicting the Prognosis, Tumor Microenvironment and Therapy Response in Breast Cancer.
Yu T; Cheng W; Zhang J; Wang T; Liu Y; Duan Y; Hu A; Feng J; Li M; Li Y; Zhang H; Rong Z; Shang Y; Shakila SS; Ma F; Guo B
J Cancer; 2024; 15(2):428-443. PubMed ID: 38169571
[TBL] [Abstract][Full Text] [Related]
10. Coordinating single-cell and bulk RNA-seq in deciphering the intratumoral immune landscape and prognostic stratification of prostate cancer patients.
Sun Z; Wang J; Zhang Q; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Liu Y; Ye F; Ma B
Environ Toxicol; 2024 Feb; 39(2):657-668. PubMed ID: 37565774
[TBL] [Abstract][Full Text] [Related]
11. Histone acetylation gene-based biomarkers as novel markers of the immune microenvironment in glioblastoma.
Yan X; Feng L; Xu Z; Chen W; Yan H; Wu P; Ding C; Zhu X; Lu Y
J Gene Med; 2023 Oct; 25(10):e3511. PubMed ID: 37097165
[TBL] [Abstract][Full Text] [Related]
12. Prognostic evaluation of the novel blueprint of DNA methylation sites by integrating bulk RNA-sequencing and methylation modification data in endometrial cancer.
Zhou H; Zhang Y; Jin J; Shen K; Yang Y; Lao P
J Gene Med; 2024 Jan; 26(1):e3638. PubMed ID: 38011892
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis identifies genetic and molecular factors associated with prognostic clusters of PANoptosis in glioma, kidney and melanoma cancer.
Mall R; Kanneganti TD
Sci Rep; 2023 Nov; 13(1):20962. PubMed ID: 38017056
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Model for Alzheimer's Disease Based on PANoptosis-Related Genes.
Zhang E; Dai F
J Alzheimers Dis; 2024; 97(2):813-828. PubMed ID: 38160361
[TBL] [Abstract][Full Text] [Related]
15. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of biomarkers related to PANoptosis in osteoarthritis.
Zhang YY; Zhao HS; Sun YF; Lu BW; Sun L
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7444-7458. PubMed ID: 37667921
[TBL] [Abstract][Full Text] [Related]
17. Identification of CREB5 as a prognostic and immunotherapeutic biomarker in glioma through multi-omics pan-cancer analysis.
Wu Z; Wang X; Wu H; Du S; Wang Z; Xie S; Zhang R; Chen G; Chen H
Comput Biol Med; 2024 May; 173():108307. PubMed ID: 38547657
[TBL] [Abstract][Full Text] [Related]
18. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
19. Pyroptosis, apoptosis, and necroptosis molecular subtype derived prognostic signature universal applicable for gastric cancer-A large sample and multicenter retrospective analysis.
Huo J; Xie W; Fan X; Sun P
Comput Biol Med; 2022 Oct; 149():106037. PubMed ID: 36044785
[TBL] [Abstract][Full Text] [Related]
20. Multi-omics approaches establishing histone modification based prognostic model in glioma patients and further verification of the carcinogenesis mechanism.
Wang Y; Ji L; Ji C; Wang F
Funct Integr Genomics; 2023 Sep; 23(4):307. PubMed ID: 37730879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]